GeoffreyWChanMD

Oncology • Collegeville, PA

Hematologic Oncology

Physician

Join to view full profile

Dr. Chan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chan's full profile

Already have an account?

Office
1250 S Collegeville Rd
Up4420
Collegeville, PA 19426
Phone+1 610-917-5256

Education & Training

Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
Tufts Medical CenterResidency, Internal Medicine, 1996 - 1999
The Warren Alpert Medical School of Brown UniversityClass of 1996

Certifications & Licensure

PA State Medical License 2007 - 2024
MA State Medical License 2000 - 2009
National Board of Physicians and Surgeons Hematology
National Board of Physicians and Surgeons Internal Medicine
National Board of Physicians and Surgeons Medical Oncology

Publications & Presentations

PubMed

349 citations
Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome
Jorge E. Cortes, Florian H. Heidel, Andrzej Hellmann, Walter Fiedler, B. Douglas Smith
Leukemia. 2019-02-01
142 citations
Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and surv...
Francine M. Foss, Gina DiVenuti, Kevin M. Chin, Kellie Sprague, H Grodman
Bone Marrow Transplantation. 2005-06-01
154 citations
Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality.
Debra D. Poutsiaka, Lori Lyn Price, A Ucuzian, Geoffrey W. Chan, Kenneth B. Miller
Bone Marrow Transplantation. 2007-04-30

Abstracts/Posters

Clinical Benefit of Glasdegib in Combination with Azacitidine or Low-Dose Cytarabine in Patients with Acute Myeloid LeukemiaClinically Relevant Abstract
Geoffrey Chan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
A Phase 1b Study of Glasdegib in Combination with Azacitidine in Patients with Untreated Higher-Risk Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Mye...
Geoffrey Chan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

New Options in Glaucoma: How MIGS Is Changing the Treatment ParadigmMarch 20th, 2023